Moriarty, Patrick M <br/><br/>
Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.  [electronic resource] 

 -  Journal of clinical lipidology   
 - 568-575 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1933-2874 
<br/><br/><label>Standard No.: </label>10.1016/j.jacl.2014.09.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Apolipoproteins A--blood<br/>Apolipoproteins B--blood<br/>Biological Products--immunology<br/>China<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Drugs, Chinese Herbal--administration & dosage<br/>Dyslipidemias--diagnosis<br/>Female<br/>Gastrointestinal Diseases--etiology<br/>Humans<br/>Hypolipidemic Agents--administration & dosage<br/>Lovastatin--therapeutic use<br/>Male<br/>Middle Aged<br/>Placebos--administration & dosage<br/>Triglycerides--blood<br/>United States